Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Thromb Haemost 1978; 40(01): 037-042
DOI: 10.1055/s-0038-1648632
DOI: 10.1055/s-0038-1648632
Original Article
Platelet Monoamine Oxidase and Epinephrine-Induced Platelet Aggregation
Further Information
Publication History
Received 15 November 1977
Accepted 04 March 1978
Publication Date:
12 July 2018 (online)
Summary
Platelet MAO activity and the aggregation response to epinephrine, ADP, and collagen were measured in normal subjects. There was a direct correlation between the amount of platelet MAO activity and the per cent aggregation induced by 1 and 2 μM epinephrine. There were lesser correlations between platelet MAO and ADP or collagen-induced aggregation. These findings suggest that platelet MAO may play a role in determining the response of human platelets to epinephrine.
-
References
- 1 Born GV R. 1962; Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194: 297
- 2 Colins GG S, Sandler M. 1971; Human blood platelet monoamine oxidase. Biochemical Pharmacology 20: 289
- 3 Friedhoff AJ, Miller JC, Karpatkin S. 1978; Heterogeneity of human Platelets. VII. Platelet monoamine oxidase activity in normals and patients with autoimmune thrombocytopenic purpura and reactive thrombocytosis: Its relationship to platelet protein density. Blood 51: 317
- 4 Gibinski K, Walendowski J, Zazgornik J. 1964; Blood platelet adhesiveness and the protective action of nialamide in atherosclerosis dysbasia. Journal of Atherosclerosis Research 4: 461
- 5 Green D, Dunne B, Schmid FR, Rossi EC, Louis G. 1973; A study of the variable response of human platelets to collagen: relation to aspirin-induced inhibition of aggregation. American Journal of Clinical Pathology 60: 920
- 6 Johnson M, Ramey E, Ramwell PW. 1975; Sex and age differences in human platelet aggregation. Nature 253: 355
- 7 Karpatkin S. 1978; Heterogeneity of Human Platelets. VI. Correlation of platelet function with platelet volume. Blood 51: 307
- 8 Latt N, Rippey JJ, Stacey RC. 1968; Monoamine oxidase activity of platelets. British Journal of Pharmacology 32: 427 P
- 9 Maschouf C, Robinson RW, Lebeau RJ. 1964; Evaluation of nialamide on the coagulation of blood. Blood 24: 289
- 10 Paasonen MK. 1961; Inactivation of 5-hydroxytryptamine by mammalian blood platelets. Biochemical Pharmacology 8: 241
- 11 Rossi EC, Levin NW. 1973; Inhibition of primary ADP-induced platelet aggregation in normal subjects after administration of nitrofurantoin (Furadantin). Journal of Clinical Investigation 52: 2457
- 12 Rossi EC, Louis G. 1975; A time-dependent increase in the responsiveness of platelet-rich plasma to epinephrine. Journal of Laboratory and Clinical Medicine 85: 300
- 13 Rossi EC, Zeller EA. 1976; Inhibition of epinephrine-induced platelet aggregation by phenylethylamine. Federation Proceedings 35: 732
- 14 Rossi EC, Louis G, Bieber M, Zeller EA. 1977; The relationship between monoamine oxidase activity and epinephrine induced platelet aggregation. Federation Proceedings 36: 453
- 15 Sabelli HC, Mosnaim AD. 1974; Phenylethylamine hypothesis of affective behavior. American Journal of Psychiatry 131: 195
- 16 Shimamoto T, Ishivka T, Fujita T. 1962; Antithrombotic effect of monoamine oxidase inhibitor (Nialamide). Circulation Research 10: 647
- 17 Snyder SH, Hendley ED. 1968; A simple and sensitive fluorescence assay for monoamine oxidase and diamine oxidase. Journal of Pharmacology and Experimental Therapeutics 163: 386
- 18 Tipton KF. 1969; A sensitive fluoremetric assay for monoamine oxidase. Analytical Biochemistry 28: 318
- 19 Weiss HJ. 1972. The pharmacology of platelet inhibition. In: Spaet TH. (ed.) Progress in Hemostasis and Thrombosis, volume 1. Grune and Stratton; New York: p 199
- 20 Wiberg A, Oreland L. 1976; Quantitative aspects on mitochondrial monoamineoxidase in human platelets. Medical Biology 54: 137
- 21 Woessner Jr JF. 1961; The determination of hydroxyproline in tissue and protein samples containing small proportions of amino acid. Archives of Biochemistry and Biophysics 93: 440
- 22 Zeller EA, Babu BH, Cavanaugh MJ, Stanich GJ. 1969; On the in vivo inhibition of human platelet monoamine oxidase by pargyline. Pharmacological Research Communications 1: 20
- 23 Zeller EA, Boshes B, Arbit J, Bieber M, Blonsky ER, Dolkart M, Huprikar SV. 1976; Molecular biology of neurological and psychiatric disorders. I. Effect of Parkinsonism, age, sex, and L-Dopa on platelet monoamine oxidase. Journal of Neural Transmission 39: 63